Lonza | LONN - Equity Capital And Reserves



Lonza reported CHF9.33B in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Akzo Nobel EUR 4.17B 452M Jun/2025
Alcon AG USD 22.13B 111M Jun/2025
Almirall EUR 1.46B 37.19M Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
BASF EUR 32.36B 3.73B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Beiersdorf EUR 8.47B 7M Jun/2025
Covestro EUR 6.15B 255M Jun/2025
Demant DKK 9.4B 168M Jun/2025
Fresenius EUR 18.94B 465M Jun/2025
Fresenius Medical Care EUR 14.33B 1.18B Jun/2025
Geberit CHF 1.54B 237.4M Mar/2025
Genmab DKK 5.3B 6M Jun/2025
Givaudan CHF 4.31B 320M Jun/2024
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GN Store Nord DKK 10.45B 304M Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Johnson Matthey GBP 2.3B 125M Mar/2025
Merck EUR 28.26B 1.64B Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Philips EUR 10.38B 1.32B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
Sika AG CHF 7.05B 621.6M Dec/2024
Smith & Nephew USD 5.54B 271M Jun/2025
Solvay EUR 1.2B 156M Jun/2025
UCB EUR 10.03B 1.08B Dec/2024